New Treatment Horizons for Deep Vein Thrombosis in

Cancer Patients

Caio Teixeira dos Santos; Alex Pereira Ramos; Ramon Magro Ferreira; Bárbara Luíza Meireles Pinheiro; Raul Ferreira de Souza Machado; Indiara Iris de Oliveira Araujo; Bruno Henrique Rala de Paula

Mini Review

New Treatment Horizons for Deep Vein Thrombosis in Cancer Patients

Caio Teixeira dos Santos¹*, Alex Pereira Ramos¹, Ramon Magro Ferreira¹, Bárbara Luíza Meireles Pinheiro¹, Raul Ferreira de Souza Machado¹, Indiara Iris de Oliveira Araujo¹ and Bruno Henrique Rala de Paula^1,2

¹Vassouras University, Rio de Janeiro, Brasil

²Medical Oncologist and Breast Cancer Researcher, INCA

Corresponding Author

Received Date: October 08, 2019; Published Date: November 06, 2019

Abstract

Venous thromboembolism (VTE), clinically manifested as deep vein thrombosis (DVT) or pulmonary embolism (PE). It is the third most common acute cardiovascular syndrome behind acute myocardial infarction and stroke [1]. It may occur before, during or after cancer diagnosis, with a relatively high incidence in cancer patients, ranging from 15 to 50% [2].

Article Details

Citation

Caio Teixeira dos Santos, Alex Pereira Ramos, Ramon Magro Ferreira, Bárbara Luíza Meireles Pinheiro, Raul Ferreira de Souza Machado, et al. New Treatment Horizons for Deep Vein Thrombosis in Cancer Patients. Adv Can Res & Clinical Imag. 2(2): 2019. ACRCI. MS.ID.000534.